Stryker CLO sells 4,544 shares in planned trades
STRYKER CORP VP and Chief Legal Officer Robert S. Fletcher sold 4,544 shares of common stock in open-market transactions on May 28, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
STRYKER CORP VP and Chief Legal Officer Robert S. Fletcher sold 4,544 shares of common stock in open-market transactions on May 28, 2026. Sale prices ranged from about $304 to $310 per share, with several trades reported at weighted average prices. The filing notes these sales were made under a Rule 10b5-1 trading plan adopted on February 26, 2026. After the transactions, he holds 10,582 shares directly and 183 shares indirectly through a 401(k) plan.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 120 | $304.225 | $37K |
| Sale | Common Stock | 165 | $305.66 | $50K |
| Sale | Common Stock | 2,809 | $306.564 | $861K |
| Sale | Common Stock | 1,067 | $307.297 | $328K |
| Sale | Common Stock | 258 | $308.785 | $80K |
| Sale | Common Stock | 125 | $310.22 | $39K |
| holding | Common Stock | -- | -- | -- |
Footnotes (5)
- F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2026.
- F2. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $305.59 to $305.665, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
- F3. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $306.05 to $306.945, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
- F4. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $307.06 to $307.76, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
- F5. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $308.78 to $308.79, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average sale price financial
open-market sale financial
401(k) financial
beneficial ownership financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider activity did Stryker (SYK) report for Robert S. Fletcher?
Was the Stryker (SYK) insider sale by Robert S. Fletcher under a Rule 10b5-1 plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.